Overview
- 35 inspections across 35 sites are on record.
- 106 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-03-01.
At a glance
Inspections
35
Sites
35
Observations
106
Career since
Apr 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Simpex Pharma Pvt. Ltd | 1 Mar 2018 | Human Drugs | View 483 → |
| Coral Drugs Private Limited | 23 Feb 2018 | Human Drugs | View 483 → |
| ENESTIA BELGIUM NV (SHARP BELGIUM) | 15 Dec 2017 | Human Drugs | |
| Groupement Interet Public Arronax | 8 Dec 2017 | Human Drugs | |
| Piramal Critical Care Inc | 22 Sep 2017 | Human Drugs | On file |
Sites inspected
Simpex Pharma Pvt. LtdSigaddi, Kotdwar, India1 insp.
Coral Drugs Private LimitedRai, India1 insp.
ENESTIA BELGIUM NV (SHARP BELGIUM)Hamont-Achel, Belgium1 insp.
Groupement Interet Public ArronaxSt Herblain, France1 insp.
Piramal Critical Care IncBethlehem, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Djamila Harouaka5 shared
Stacie A Woods3 shared
Valerie L Whipp2 shared
Zhongren Wu2 shared
Tajah L Blackburn2 shared
Jonathan W Chapman2 shared
Bryce A Hammer2 shared
Brittany R Laymon2 shared
Felix J Marrero2 shared
Lance A Finnical1 shared
Full investigator report
Get the verbatim findings behind Jai P Singh's 106 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site